BSE, Angel One, IIFL Securities and 5 Paisa will be in focus because the Securities And Exchange Board Of India has increased ...

Aurobindo Pharma's subsidiary Apitoria Pharma has received 10 observations from the USFDA for its API manufacturing facility ...

AM(IST)on Thursday in a weak market. Granules India Ltd.(up 2.91 per cent), Aurobindo Pharma Ltd.(up 1.31 per cent), Torrent ...

Hyderabad: Aurobindo Pharma Limited has announced that it has received final approval from the US Food & Drug Administration ...

Maruti Suzuki reported a nearly 2% jump in September total sales at 1,84,727 units versus 1,81,343 units in the corresponding ...

Shares of Aurobindo Pharma fell 4.49% to a low of Rs 1,443.5 apiece on the NSE. The stock later pared losses to trade 2.21% ...

Last week, brokerage firm UBS Securities also initiated a 'sell' call on Aurobindo Pharma, assigning it a price target of Rs ...

Aurobindo Pharma receives USFDA approval for Cephalexin tablets, expected to launch in Q3FY25 with CGT designation.

Aurobindo Pharma's subsidiary, Apitoria Pharma, received 10 observations from the USFDA after an inspection of its API ...

Zydus Lifesciences, Maruti Suzuki India, Dabur India, South Indian Bank, Allcargo Logistics, International Conveyors, NMDC, ...

The USFDA has issued 10 observations to Aurobindo Pharma's API manufacturing unit in Telangana after a September 2024 ...

Aurobindo Pharma gains FDA approval for Cephalexin Tablets, bioequivalent to Keflet, with CGT designation and shared exclusivity.